Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation
Yun Shi(Army Medical University), Zhiqiang An(Brown Foundation)
Cited by 62
Related Papers
Antibody-drug conjugates: recent advances in conjugation and linker chemistries
|Protein & Cell|2016|746
HER3 and LINC00052 interplay promotes tumor growth in breast cancer
|Oncotarget|2016|32